MedPath

Safety and efficacy of oral Ketamine in resistant depressio

Phase 2
Conditions
Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic featuresHealth Condition 2: F330- Major depressive disorder, recurrent, mildHealth Condition 3: F331- Major depressive disorder, recurrent, moderateHealth Condition 4: F320- Major depressive disorder, singleepisode, mildHealth Condition 5: F321- Major depressive disorder, singleepisode, moderateHealth Condition 6: F322- Major depressive disorder, singleepisode, severe without psychotic features
Registration Number
CTRI/2023/06/054271
Lead Sponsor
Department of psychiatry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. All participants who have not responded adequately to therapeutic trials of 2 antidepressants of different classes given in adequate dose for 6 weeks.

2. Participants should be on stable medication of antidepressants for a period of at least 6 weeks.

3. Able to give informed consent.

Exclusion Criteria

1. Participants who have taken Ketamine treatment (in any route) for depression before.

2. Participants having any known gastrointestinal issues or oral ulcers or diseases.

3. Pregnant participants.

4. Participants with age <18.

5. Any other serious medical condition.

6. Any other associated psychiatric disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessing Safety & efficacy of oral ketamine in treatment resistant depressionTimepoint: 10 VISITS <br/ ><br>1st week 3 visits <br/ ><br>2nd week 3 visits <br/ ><br>3rd week 2 visits <br/ ><br>4rth week 2 visits <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
Assess improvement in treatment resistant depression with active suicidal ideationTimepoint: 10 visits <br/ ><br>1st week 3 visits <br/ ><br>2nd week 3 visits <br/ ><br>3rd week 2 visits <br/ ><br>4rth week 2 visits <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath